{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-002127","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2023-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.349109+00:00","generated_at":"2026-06-20T12:09:24.973931+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Lineage Cell Therapeutics furnishes corporate investor presentation dated Jan 23, 2023","bullets":["Presentation covers Lineage's product candidates and recent business developments.","Filed under Regulation FD; presentation furnished, not filed.","No specific financial or operational updates disclosed in available text."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-002127","json":"https://secwatch.observer/filing/0001493152-23-002127.json","markdown":"https://secwatch.observer/filing/0001493152-23-002127.md","text":"https://secwatch.observer/filing/0001493152-23-002127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000149315223002127/0001493152-23-002127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000149315223002127/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T12:09:24.973931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}